TRK CANCER Bayer Logo Bayer Logo Bayer Logo

GENOMIC PROFILING

Genomic profiling can identify actionable alterations

We now know that cancer is a disease of the genome.1 Studies indicate that 30% to 49%
of patients who undergo tumor genomic profiling may have an actionable Actionable means that the alteration is associated with an approved or investigational therapy. alteration.2,3

30% to 49% of patients who undergo tumor genomic profiling may have an actionable alteration2,3